Search Results - "Taher, Rashida"

Outcomes of Primary Central Nervous System Lymphoma (PCNSL) Treated with Immunochemotherapy or Chemotherapy Alone: Analysis of the National Cancer Data Base 2013-2018 by Ollila, Thomas A., Taher, Rashida, Grado, Stephen, Olszewski, Adam J.

Get full text

Reassessing the risks and benefits of COVID-19 precautions in 2023 by Ollila, Thomas A., Taher, Rashida, Moku, Prashanth

Get full text

Seroconversion and outcomes after initial and booster COVID‐19 vaccination in adults with hematologic malignancies by Ollila, Thomas A., Masel, Rebecca H., Reagan, John L., Lu, Shaolei, Rogers, Ralph D., Paiva, Kimberly J., Taher, Rashida, Burguera‐Couce, Ella, Zayac, Adam S., Yakirevich, Inna, Niroula, Rabin, Barth, Peter, Olszewski, Adam J.

“…Background Patients with hematologic malignancies have impaired humoral immunity secondary to their malignancy and its treatment, placing them at risk of…”
Get full text

Immunochemotherapy or Chemotherapy Alone in Primary Central Nervous System Lymphoma, a National Cancer Data Base Analysis by Ollila, Thomas A, Taher, Rashida, Moku, Prashanth, Olszewski, Adam J

“…Debate remains over the role of rituximab, a large molecule with reduced central nervous system (CNS) penetration, in therapy for primary CNS lymphoma (PCNSL)…”
Get full text

Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies by Ollila, Thomas A., Masel, Rebecca, Reagan, John L, Paiva, Kimberly, Lu, Shaolei, Rogers, Ralph, Zayac, Adam, Taher, Rashida, Yakirevich, Inna, Niroula, Rabin, Barth, Peter, Olszewski, Adam J.

“…Background: Recent studies reported low rates of seroconversion response to COVID-19 vaccination in patients (pts) with hematologic malignancies (HMs). Vaccine…”
Get full text

Immunochemotherapy or chemotherapy alone in primary central nervous system lymphoma: a National Cancer Database analysis by Ollila, Thomas A., Taher, Rashida, Moku, Prashanth, Olszewski, Adam J.

“…•In a matched analysis, immunotherapy use was associated with improved OS in PCNSL (HR, 0.75; 95% CI, 0.67-0.83).•Reduced immunotherapy use was associated with…”
Get full text

Referral Strategies to a Tobacco Quitline and Racial and/or Ethnic Differences in Participation by Russo, Elizabeth T, Reid, Margaret, Taher, Rashida, Sharifi, Mona, Shah, Snehal N

“…Tobacco use inflicts a disproportionate burden of disease on people of color. We evaluated the reach among African American and Hispanic smokers in Boston of 2…”
Get full text

Clinical Trial Design and Drug Approval in Oncology: A Primer for the Advanced Practitioner in Oncology by Kurtin, Sandra E, Taher, Rashida

“…Evidenced-based practice requires timely and accurate integration of scientific advances. This presents a challenge for the oncology clinician given the robust…”
Get full text

Diagnostic Snapshot: A Patient With Gastrointestinal Symptoms and Eosinophilia by Taher, MPH, PA-C, Rashida, E. Kurtin, PhD, ANP-C, AOCN, Sandra

Get full text